The first stop for professional medicines advice

Medication Safety

54 results

Applied filters

Product Risk Assessment Tools

15 March 2016Product risk assessment tools to support NHS organisations to identify risk resultant from medicinal product presentation.

Guidance on Handling of Injectable Cytotoxic Drugs in Clinical Areas in in NHS Hospitals in the UK (Yellow Cover) Edition 1 July 2018

31 July 2018Intended audience: This document is intended as a reference and source of information to the following audiences: Nursing staff who handle cytotoxic chemotherapy (Oncology /…

Multiple Use of Injectable Medicines in Clinical Areas V 02 February 2020

19 December 2019This document is intended for multi-professional clinical practitioners to use as a reference and source of information for the prescribing, reconstituting or administering injectable medicines.…

Safe practice for handling multiple COVID-19 vaccines

2 March 2021A number of COVID-19 vaccines are available, all with different handling and dosing requirements; sites need to plan to reduce the risk of errors

Good governance guidance when handling multiple COVID-19 vaccines

2 March 2021Practice points to ensure good governance when planning or designing vaccination services where multiple vaccines are used.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

Managing risks of betamethasone soluble tablets used as mouthwash

9 July 2021Serious side effects can be caused if betamethasone soluble tablets used as mouthwash are swallowed. Providing clear patient directions can help prevent harm.

Using potassium permanganate for skin conditions or wound care

15 November 2021Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.

Managing risk when supplying and administering COVID-19 treatments across the system

20 December 2021Differing models exist for the supply and administration of COVID-19 treatments. We guide through the risks and mitigations associated with each.

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.